Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pregnenolone Augmentation in the Management of Schizophrenia Patients: a Randomised Double-Blind Placebo-Controlled Trial

NCT00174889 is registered in ClinicalTrials.gov with Sha'ar Menashe Mental Health Center as lead sponsor.

NCT NCT00174889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pregnenolone Augmentation in the Management of Schizophrenia Patients: a Randomised Double-Blind Placebo-Controlled Trial
Lead sponsor
Sha'ar Menashe Mental Health Center
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia